TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
AGB-Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
22,828
|
21,768
|
16,284 |
Financial expenses |
72
|
1
|
0 |
Earnings before taxes |
7,586
|
11,131
|
4,508 |
EBITDA |
7,322
|
11,006
|
4,579 |
Total assets |
16,666
|
16,073
|
14,405 |
Current assets |
15,750
|
15,360
|
13,626 |
Current liabilities |
7,324
|
4,824
|
2,107 |
Equity capital |
8,731
|
10,849
|
11,933 |
- share capital |
5
|
4
|
5 |
Employees (average) |
17
|
11
|
6 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
52.4%
|
67.5%
|
82.8% |
Turnover per employee |
1,343
|
1,979
|
2,714 |
Profit as a percentage of turnover |
33.2%
|
51.1%
|
27.7% |
Return on assets (ROA) |
45.9%
|
69.3%
|
31.3% |
Current ratio |
215.0%
|
318.4%
|
646.7% |
Return on equity (ROE) |
86.9%
|
102.6%
|
37.8% |
Change turnover |
996
|
6,804
|
16,284 |
Change turnover % |
5%
|
45% | |
Chg. No. of employees |
6
|
5
|
4 |
Chg. No. of employees % |
55%
|
83%
|
200% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.